Median Technologies Reschedules Its Corporate Update Webcasts on May 4, 2023

Regulatory News:

Median Technologies (ALMDT:PA) announced today that the two webcasts during which Fredrik Brag, CEO and Founder will provide a corporate update, are rescheduled from May 3^rd to May 4^th, 2023. New registration links are below.

• Webcast held in English: at 4:00 pm CEST / 10:00 am EDT
  Registration link: https://register.gotowebinar.com/register/7324060688550180191

• Webcast held in French: at 6:00 pm CEST / 12:00 pm EDT
• Registration link: https://register.gotowebinar.com/register/4126422489745055066

Webcast replays will be available on Median’s corporate website after the live sessions.

About Median Technologies: Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and iBiopsy®, our AI-powered imaging platform for the development of Software as Medical Devices (SaMD) help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.

Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label "Innovative company” by the BPI and is listed on Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME). For more information: www.mediantechnologies.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20230425005861/en/